Alternative splicing events expand molecular diversity of camel CSN1S2 increasing its ability to generate potentially bioactive peptides

Scientific Reports
Alma RyskaliyevaP Martin


In a previous study on camel milk from Kazakhstan, we reported the occurrence of two unknown proteins (UP1 and UP2) with different levels of phosphorylation. Here we show that UP1 and UP2 are isoforms of camel αs2-CN (αs2-CNsv1 and αs2-CNsv2, respectively) arising from alternative splicing events. First described as a 178 amino-acids long protein carrying eight phosphate groups, the major camel αs2-CN isoform (called here αs2-CN) has a molecular mass of 21,906 Da. αs2-CNsv1, a rather frequent (35%) isoform displaying a higher molecular mass (+1,033 Da), is present at four phosphorylation levels (8P to 11P). Using cDNA-sequencing, αs2-CNsv1 was shown to be a variant arising from the splicing-in of an in-frame 27-nucleotide sequence encoding the nonapeptide ENSKKTVDM, for which the presence at the genome level was confirmed. αs2-CNsv2, which appeared to be present at 8P to 12P, was shown to include an additional decapeptide (VKAYQIIPNL) revealed by LC-MS/MS, encoded by a 3'-extension of exon 16. Since milk proteins represent a reservoir of biologically active peptides, the molecular diversity generated by differential splicing might increase its content. To evaluate this possibility, we searched for bioactive peptides encrypted i...Continue Reading


Mar 16, 1992·Biochemical and Biophysical Research Communications·P Martin, C Leroux
Oct 25, 1991·Nucleic Acids Research·D KoczanH M Seyfert
Dec 11, 1990·Nucleic Acids Research·D W Threadgill, J E Womack
Jul 1, 1995·The Biochemical Journal·L B JohnsenL Berglund
Mar 1, 1995·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·J E Allende, C C Allende
Jan 30, 1993·Gene·M A GroenenJ J van der Poel
Jun 17, 1998·The Journal of Dairy Research·S KappelerZ Puhan
Jul 6, 2000·Journal of Dairy Science·D A Clare, H E Swaisgood
Oct 31, 2001·Animal Genetics·L RamunnoA Rando
May 20, 2003·Journal of Mammary Gland Biology and Neoplasia·Monique Rijnkels
Jul 27, 2004·Proteomics·Guy MirandaPatrice Martin
Jan 5, 2005·BioFactors·Hans Meisel
Nov 2, 2006·Briefings in Bioinformatics·Carolina Perez-IratxetaJonathan D Wren
Oct 31, 2009·Reproduction, Fertility, and Development·Christophe M LefèvreKevin R Nicholas
Sep 14, 2012·Journal of Mass Spectrometry : JMS·Rosaria SalettiSalvatore Foti
Jun 25, 2013·Applied and Environmental Microbiology·Avelino Alvarez-OrdóñezColin Hill
Feb 13, 2014·Electrophoresis·Besma SaadaouiChristelle Cebo
Sep 10, 2014·Journal of Dairy Science·E BijlH Bovenhuis
Dec 3, 2014·Food Chemistry·Akio YamadaFumiaki Abe
Jun 20, 2015·Cell·Vincent S TagliabracciJack E Dixon
Jul 28, 2015·Scientific Reports·Ravi KumarGajendra P S Raghava
May 7, 2016·British Journal of Clinical Pharmacology·Simone MarconeDesmond J Fitzgerald
Sep 1, 2016·Saudi Journal of Biological Sciences·D P MohantyP S Sahu
Aug 9, 2017·Food Research International·Vincenzo CunsoloSalvatore Foti
Mar 29, 2018·Bioinformatics·Daniel VeltriAmarda Shehu

❮ Previous
Next ❯

Datasets Mentioned


Methods Mentioned

two hybrids

Software Mentioned

BIOPEP Prediction Software Tools

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.